Neurogen Corporation Announces Webcast of Third Quarter 2007 Financial Results on November 1

Neurogen Corporation (NASDAQ:NRGN), a drug discovery and development company, announced today that it will release its third quarter 2007 financial results on Thursday, November 1, 2007 before the opening of the U.S. financial markets. The Company will host a conference call and live audio webcast that same day at 8:30 a.m. ET to review the results. The news release and live webcast may be accessed through the investor relations section of the Company's web site: www.neurogen.com. The webcast will be also be archived in this section, under "Events Calendar and Replays." About Neurogen Neurogen Corporation is a drug discovery and development company focusing on small molecule drugs to improve the lives of patients suffering from disorders with significant unmet medical need, including insomnia, Parkinson’s disease and restless legs syndrome (RLS), pain, obesity, and depression. Neurogen conducts its research and development independently and, when advantageous, collaborates with world-class pharmaceutical companies to access additional resources and expertise.